Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
€277.60

€277.60

0.290%
0.8
0.290%
-

-

 
31.07.26 / Frankfurt WKN: A14Y65 / Name: Penumbra / Stock / Healthcare Equipment & Supplies / Mid Cap /
Latest predictions
17.04.26
-1.70%
buy
Your prediction

Penumbra Inc Stock

The Penumbra Inc stock is trending slightly upwards today, with an increase of €0.80 (0.290%) compared to yesterday's price.

Pros and Cons of Penumbra Inc in the next few years

Pros
?
W********* I********* f** t** n*** y****
?
G***** c******* t* c**********
?
B****
Cons
?
M***** P*******
?
S********** s********
?
C******** o* t** e**********
Tell us your opinion to access the 'Wisdom of the Crowds'

Performance of Penumbra Inc vs. its peers

Security Change(%) 1w 1m 1y YTD 3y 5y
Penumbra Inc 0.290% -0.786% 0.507% 26.239% 4.204% 1.314% 23.268%
Bio-Rad Labs Inc. A -0.480% 2.732% 11.380% 30.502% 10.818% -24.392% -54.272%
CONMED Corp. 0.500% 7.979% 42.958% -6.881% 16.000% -62.056% -64.696%
Glaukos Corp 10.770% 8.271% 18.033% 73.494% 49.223% 110.219% 239.623%

News

3 Medical Device Stocks Giving Investors a Different Healthcare PlayPhoto, wide shot, wide-angle lens,  Mental health care service, Midday, harsh overhead sunlight, directional sunlightt, photo by Art Wolfe: https://img.midjourneyapi.xyz/temp/7ce3b930-5e2a-4215-b686-0ad0eb0b922a.png
3 Medical Device Stocks Giving Investors a Different Healthcare Play

Key Points

Why Boston Scientific's Big Dip Could Be a Bigger OpportunityPhoto, wide shot, wide-angle lens,  Mental health care service, Midday, harsh overhead sunlight, directional sunlightt, photo by Art Wolfe: https://img.midjourneyapi.xyz/temp/7ce3b930-5e2a-4215-b686-0ad0eb0b922a.png
Why Boston Scientific's Big Dip Could Be a Bigger Opportunity

Medical device manufacturer Boston Scientific Corp. (NYSE: BSX) is seemingly off to a tough start to the year, as shares have plunged by 26% year-to-date (YTD) and by almost a third in the last